eCourse
Hot Topics in Pharma and Lifesciences Patent Litigation
Contains material from Dec 2019
Hot Topics in Pharma and Lifesciences Patent Litigation
4.13 out of 5 stars
What was the overall quality of the course (presentation, materials, and technical delivery)?
Rate the overall teaching effectiveness and presentation skills of faculty for the course.
How would you rate the value of the materials provided as part of the course?
Technical Questions?
512.475.6700
service@utcle.org
Session 1: Hot Topics in Hatch-Waxman, Pharmaceuticals, and Life Sciences Patent Litigation - An overview of recent decisions in Hatch-Waxman, pharmaceuticals, and life sciences patent cases, plus trends that have developed due to those decisions.
Session 2: Case Law and Regulatory Antitrust Developments Post-Actavis - Complaints about drug prices have lead to expansion of antitrust problems for Pharma. Legislation has imposed new government reporting requirements for patent licenses in the Pharma industry. Other legislation is pending to impose new antitrust risks and penalties on the Pharma industry. Case law on “reverse settlements” has snowballed since FTC v. Actavis, and now reaches even non-cash settlement terms. Standard-setting has now become a part of the Pharma and medical device industry, bringing with it disclosure, FRAND and antitrust issues. Hear more on enacted and pending legislation, case law developments, and future trends in antitrust in the Pharma Industry.
Session 2: Case Law and Regulatory Antitrust Developments Post-Actavis - Complaints about drug prices have lead to expansion of antitrust problems for Pharma. Legislation has imposed new government reporting requirements for patent licenses in the Pharma industry. Other legislation is pending to impose new antitrust risks and penalties on the Pharma industry. Case law on “reverse settlements” has snowballed since FTC v. Actavis, and now reaches even non-cash settlement terms. Standard-setting has now become a part of the Pharma and medical device industry, bringing with it disclosure, FRAND and antitrust issues. Hear more on enacted and pending legislation, case law developments, and future trends in antitrust in the Pharma Industry.
Includes: Video Audio Paper Slides
Preview mode.
You must be signed in, have purchased this eCourse,
and the eCourse must be active
to have full access.
Preview Sessions
Show session details
1.
Hot Topics in Hatch-Waxman, Pharmaceuticals, and Life Sciences Patent Litigation (Dec 2019)
Aden M. Allen, J. Nicole Stafford
0.50
0.00
0.00
Preview Materials
Download session materials for offline use
Session 1
—31 mins
Hot Topics in Hatch-Waxman, Pharmaceuticals, and Life Sciences Patent Litigation (Dec 2019)
An overview of recent decisions in Hatch-Waxman, pharmaceuticals, and life sciences patent cases, plus trends that have developed due to those decisions.
Originally presented: Nov 2019 Advanced Patent Law Institute
Aden M. Allen,
Wilson Sonsini Goodrich & Rosati, P.C. - Austin, TX
J. Nicole Stafford,
Wilson Sonsini Goodrich & Rosati, P.C. - Austin, TX
Show session details
2.
Case Law and Regulatory Antitrust Developments Post-Actavis (Dec 2019)
Danielle Joy "DJ" Healey
0.50
0.00
0.00
Preview Materials
Download session materials for offline use
Session 2
—30 mins
Case Law and Regulatory Antitrust Developments Post-Actavis (Dec 2019)
Complaints about drug prices have lead to expansion of antitrust problems for Pharma. Legislation has imposed new government reporting requirements for patent licenses in the Pharma industry. Other legislation is pending to impose new antitrust risks and penalties on the Pharma industry. Case law on “reverse settlements” has snowballed since FTC v. Actavis, and now reaches even non-cash settlement terms. Standard-setting has now become a part of the Pharma and medical device industry, bringing with it disclosure, FRAND and antitrust issues. Hear more on enacted and pending legislation, case law developments, and future trends in antitrust in the Pharma Industry.
Originally presented: Nov 2019 Advanced Patent Law Institute
Danielle Joy "DJ" Healey,
Fish & Richardson P.C. - Houston, TX